We are live on
!
Find out more
Marshall Wace Portfolio holdings
AUM
$100B
1-Year Est. Return
35.1%
This Fund
S&P 500
This Quarter
Est. Return
-12.49%
1 Year Est. Return
+35.1%
3 Year Est. Return
+111.04%
5 Year Est. Return
+146.93%
10 Year Est. Return
+632.23%
AUM
$48.6B
AUM Growth
-$4.2B
(-8%)
Cap. Flow
+$3.6B
Cap. Flow
% of AUM
7.4%
Top 10 Holdings %
Top 10 Hldgs %
10.29%
Holding
4,108
New
835
Increased
963
Reduced
740
Closed
743
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Eli Lilly
LLY
|
+$340M |
| 2 |
Bank of America
BAC
|
+$302M |
| 3 |
Cigna
CI
|
+$294M |
| 4 |
TSMC
TSM
|
+$275M |
| 5 |
Union Pacific
UNP
|
+$256M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Verizon
VZ
|
+$426M |
| 2 |
S&P Global
SPGI
|
+$413M |
| 3 |
Booking.com
BKNG
|
+$264M |
| 4 |
Comcast
CMCSA
|
+$256M |
| 5 |
Teleflex
TFX
|
+$241M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 17.59% |
| 2 | Financials | 16.96% |
| 3 | Technology | 16.37% |
| 4 | Consumer Discretionary | 9.32% |
| 5 | Industrials | 7.7% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
176
Carvana
CVNA
$77.9B
| $57.3M | 0.12% |
12,694,585
+12,568,350
| +9,956% | +$132M |
|
177
PUT
State Street SPDR S&P Regional Banking ETF
KRE
$4.64B
| $57.2M | 0.12% |
985,200
+523,700
| +113% | +$32.7M |
|
178
Zurn Elkay Water Solutions
ZWS
$8.53B
| $57.2M | 0.12% |
2,099,958
+901,515
| +75% | +$27.3M |
|
179
Boeing
BA
$185B
| $57.2M | 0.12% |
418,362
+276,361
| +195% | +$40.8M |
|
180
Dollar General
DG
$27.9B
| $57.2M | 0.12% |
232,909
-241,712
| -51% | -$56.4M |
|
181
Philip Morris
PM
$295B
| $56.9M | 0.12% |
576,570
+124,515
| +28% | +$12.7M |
|
182
CoStar Group
CSGP
$12.3B
| $56.3M | 0.12% |
+932,481
| New | +$56.5M |
|
183
Aptiv
APTV
$10.3B
| $55.6M | 0.11% |
624,581
+596,834
| +2,151% | +$60.9M |
|
184
CALL
Occidental Petroleum Corp Warrants
OXY.WS
$32B
| $54.5M | 0.11% |
925,650
| – | – |
|
185
Constellium
CSTM
$3.99B
| $53.8M | 0.11% |
4,069,517
+154,110
| +4% | +$2.46M |
|
186
Jabil
JBL
$35.8B
| $53.7M | 0.11% |
1,048,031
+36,159
| +4% | +$2.09M |
|
187
Cytokinetics
CYTK
$10.4B
| $53.2M | 0.11% |
1,353,137
+1,322,232
| +4,278% | +$53.2M |
|
188
Armstrong World Industries
AWI
$7.84B
| $53.1M | 0.11% |
707,984
+668,125
| +1,676% | +$56.5M |
|
189
Lyft
LYFT
$6.63B
| $52.9M | 0.11% |
3,981,336
+2,296,524
| +136% | +$53.5M |
|
190
Expeditors International
EXPD
$23.2B
| $52.3M | 0.11% |
536,888
-43,231
| -7% | -$4.43M |
|
|
SAGE
191
DELISTED
Sage Therapeutics
SAGE
| $52.2M | 0.11% |
1,615,306
+981,273
| +155% | +$32.9M |
|
|
PSTH
192
DELISTED
Pershing Square Tontine Holdings, Ltd.
PSTH
| $51.4M | 0.11% |
2,574,114
+65,725
| +3% | +$1.31M |
|
193
SLB Ltd
SLB
$75B
| $51.4M | 0.11% |
1,436,218
-55,437
| -4% | -$2.31M |
|
194
Monolithic Power Systems
MPWR
$68.9B
| $51.1M | 0.11% |
133,108
+7,559
| +6% | +$3.19M |
|
195
Ares Capital
ARCC
$14.4B
| $51M | 0.11% |
2,847,151
-1,168,706
| -29% | -$23M |
|
196
Petrobras
PBR
$116B
| $50.9M | 0.1% |
+4,357,066
| New | +$60.3M |
|
197
Mondelez International
MDLZ
$79.9B
| $50.8M | 0.1% |
818,033
+643,610
| +369% | +$40.7M |
|
198
PUT
Netflix
NFLX
$309B
| $50.2M | 0.1% |
2,871,000
+1,845,000
| +180% | +$40.9M |
|
|
ASZ
199
DELISTED
Austerlitz Acquisition Corporation II
ASZ
| $50.2M | 0.1% |
5,144,032
| – | – |
|
200
BJs Wholesale Club
BJ
$12.3B
| $50.1M | 0.1% |
+804,643
| New | +$50.6M |
|
Similar funds
Marshall Wace's Q2 2022 Portfolio in Review
As of Q2 2022, Marshall Wace held 4,108 positions worth $48.6B, down 8% from $52.8B the previous quarter. Its ten largest holdings account for 10% of the portfolio.
Marshall Wace deployed $3.6B of net new capital in Q2 2022, opening 835 new positions and adding to 963 existing holdings. Its largest new stake was Eli Lilly: 1,133,393 shares worth $367M.
By sector, the portfolio is most concentrated in Healthcare at 18% of assets, up from 16% a quarter earlier, followed by Financials and Technology.
On the sell side, the largest reduction was Verizon, an estimated $426M trimmed.
- Marshall Wace's largest Q2 2022 buy was Eli Lilly: 1,133,393 shares worth $367M.
- Marshall Wace added most to Bank of America in Q2 2022, an estimated $302M increase.
- Marshall Wace's biggest Q2 2022 reduction was Verizon, cutting an estimated $426M.
- Marshall Wace fully exited Teleflex in Q2 2022, selling an estimated $241M.
- Marshall Wace's ten largest holdings make up 10% of its $48.6B portfolio in Q2 2022.
- Marshall Wace opened 835 new positions and closed 743 in Q2 2022.
- Marshall Wace's portfolio value fell 8% quarter-over-quarter to $48.6B.
Based on Marshall Wace's 13F filing for Q2 2022, filed 15 Aug 2022.